BNP Paribas Financial Markets
OCAT

BNP Paribas Financial Markets’s OCATA THERAPEUTICS, INC. COMMON STOCK OCAT Stock Holding History

BNP Paribas Financial Markets’s Portfolio OCAT Stock Details OCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-5,098
Closed -$42.9K – 3519
2015
Q4 		$42.9K Sell
5,098
-3,579
-41% -$24K ﹤0.01% 2914
2015
Q3 		$36.3K Buy
8,677
+5,709
+192% +$24.9K ﹤0.01% 3074
2015
Q2 		$15.6K Buy
+2,968
New +$19K ﹤0.01% 3197

BNP Paribas Financial Markets's OCAT Position: Q1 2016 in Review

BNP Paribas Financial Markets sold out of OCATA THERAPEUTICS, INC. COMMON STOCK (OCAT) in Q1 2016, closing a stake of 5,098 shares — an estimated $42.9K sold.

BNP Paribas Financial Markets first reported a position in OCAT in Q2 2015 and held it in 3 quarters. The position peaked at $42.9K in Q4 2015. 1 fund tracked by Wall St. Rank holds OCAT as of Q1 2016.

  • BNP Paribas Financial Markets reported no remaining OCATA THERAPEUTICS, INC. COMMON STOCK position as of Q1 2016 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 5,098 OCATA THERAPEUTICS, INC. COMMON STOCK shares in Q1 2016, an estimated $42.9K.
  • BNP Paribas Financial Markets first reported a position in OCATA THERAPEUTICS, INC. COMMON STOCK in Q2 2015 and held it in 3 quarters.
  • BNP Paribas Financial Markets's OCATA THERAPEUTICS, INC. COMMON STOCK position peaked at $42.9K in Q4 2015.
  • 1 fund tracked by Wall St. Rank held OCATA THERAPEUTICS, INC. COMMON STOCK as of Q1 2016.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2016, filed 22 Apr 2016.